NEW VIDEO

Vitargus®

A Biodegradable, Next-Generation Vitreous Replacement

NEW VIDEO

ABV-1504

A Novel New Treatment for Major Depressive Disorder

NEW VIDEO

ABV-1505

A Plant-based Drug Targeting ADHD Symptoms in Adults

ABVC Subsidiary BioKey, Inc. provides contract development and manufacturing services for nutritional and pharmaceutical products.

GROWING PIPELINE

Our portfolio of medicines is dedicated to the development of natural, plant-based medications that target severe illnesses impacting millions of people worldwide. We have the support of cutting-edge research done at famous medical institutions around the world on ophthalmology, depression, ADHD, and oncology. With support from our partners we are ready to advance our strong portfolio into phase III clinical trials.

FOCUS ON BOTANICALS

Plant based medicine has a long history of relieving or preventing many diseases typically with fewer side effects. The global market for herbal medicine wasUSD 165 billion in 2021. This is expected to grow to USD 347.50 billion by 2029 (11% CAGR) (source: fortune business insights). We are currently making significant progress in the development of several pharmaceuticals derived from botanical sources, with promising results.

RESEARCH PARTNERS

The relationships our management team has developed with skilled scientists and researchers worldwide is at the core of our success. With trials ongoing in Thailand, Australia, Taiwan, and Stanford University, ABVC is well-supported to bring multiple drugs to commercialization within the next five years.

VIDEO PRESENTATION

Botanical Products

VIDEO PRESENTATION

General Introduction

NASDAQ: ABVC

Latest News

THERAPEUTIC FOCUS

Depression in Cancer Patients

THERAPEUTIC FOCUS

Adults with ADHD

ABVC Investor Presentation

View the latest product information, status updates, financial information, and more.

BACKGROUND

Collaborative Partners

NASDAQ: ABVC

Vital Statistics

PRICE: $0.553 VOLUME: 104,186

BACKGROUND

Company Leadership

Contact ABVC BioPharma

Contact ABVC BioPharma

TELEPHONE

+1 845-291-1291

44370 Old Warm Springs Boulevard
Fremont, California 94538 USA
CONTACT FORM

DISCLAIMER: Clinical trials may be in early stages. There is no guarantee that any specific outcome will be achieved. Investments may be speculative, illiquid and there is a risk of loss. Past performance is not indicative of future results.

SAFE HARBOR STATEMENT: With the exception of historical information, the matters discussed in this website are forward-looking statements that involve a number of risks and uncertainties. The actual future results of ABVC could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the company’s operations, inability to hire and retain qualified personnel, and changes in the general economic climate. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential” or “continue,” the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by ABVC, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. This website does not constitute an offer to sell or a solicitation of offers to buy any securities of any entity.